Securities Code: 002432 Securities Abbreviation: Anjian Medical Announcement Number: 2026-051
Tianjin Anjian Medical Electronic Co., Ltd.
Announcement on the First Sale of Repurchased Shares and Reaching 1% Threshold
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.
Tianjin Anjian Medical Electronic Co., Ltd. (hereinafter referred to as the "Company") convened the fifth meeting of the seventh Board of Directors on April 30, 2026, and reviewed and approved the "Proposal on the Plan for Selling Repurchased Shares Through Centralized Bidding." The Company agreed to sell part of its repurchased shares through centralized bidding, with a planned sale of no more than 9,295,000 shares. The implementation period is from May 28, 2026, to November 20, 2026. The total number of shares sold in this overall sale shall not exceed 2% of the Company's total share capital, and within any consecutive 90-day period during the implementation period, the number of shares sold by the Company shall not exceed 1% of the Company's total share